Literature DB >> 11235988

Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation.

Y Sawaji1, T Sato, M Seiki, A Ito.   

Abstract

We have previously reported that heat shock suppresses the production and gene expression of membrane type 1-matrix metalloproteinase (MT1-MMP) and thereby inhibits the activation of progelatinase A/proMMP-2 in human fibrosarcoma HT-1080 cells and human squamous carcinoma A431 cells and SAS cells (Sato et al. Biochem Biophys Res Commun 1999; 265: 189-93). In an effort to clarify the heat shock-mediated signal transduction pathways, an intracellular cAMP level was found to be transiently augmented in the heat shocked HT-1080 cells. When HT-1080 cells were pretreated with cAMP elevating reagents, forskolin and dibutyryl cAMP for 4 h instead of heat shock and then maintained in a fresh medium, the production and gene expression of MT1-MMP were similarly suppressed. The MT1-MMP-mediated activation of proMMP-2 was also inhibited in the forskolin- and dibutyryl cAMP-treated HT-1080 cells. Furthermore, the transiently augmented cAMP by forskolin as well as heat shock interfered with in vitro invasive activity of HT-1080 cells. In contrast, in normal human fibroblasts neither heat shock nor cAMP elevating reagents altered the concanavalin A-augmented MT1-MMP production and proMMP-2 activation. These results suggest that a transient increase in intracellular cAMP is a critical signal for heat shock to induce tumor specific-suppression of MT1-MMP production and proMMP-2 activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11235988     DOI: 10.1023/a:1006760021997

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  39 in total

1.  Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation.

Authors:  M Yu; H Sato; M Seiki; S Spiegel; E W Thompson
Journal:  FEBS Lett       Date:  1997-08-04       Impact factor: 4.124

2.  Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.

Authors:  G Velasco; S Cal; A Merlos-Suárez; A A Ferrando; S Alvarez; A Nakano; J Arribas; C López-Otín
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

3.  Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.

Authors:  T Sato; Y Sawaji; N Matsui; H Sato; M Seiki; Y Mori; A Ito
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

Review 4.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

5.  Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

Authors:  H Ueno; H Nakamura; M Inoue; K Imai; M Noguchi; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

6.  Cyclic AMP--an intracellular second messenger for interleukin 1.

Authors:  F Shirakawa; U Yamashita; M Chedid; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Heat shock of human synovial and dermal fibroblasts induces delayed up-regulation of collagenase-gene expression.

Authors:  E G Hitraya; J Varga; S A Jimenez
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

8.  Cyclic adenosine 3',5'-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts.

Authors:  S Takahashi; A Ito; M Nagino; Y Mori; B Xie; H Nagase
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

9.  Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin.

Authors:  B A Vance; C G Kowalski; C E Brinckerhoff
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

10.  Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.

Authors:  T Sato; M Iwai; T Sakai; H Sato; M Seiki; Y Mori; A Ito
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

View more
  5 in total

1.  Hyperthermia inhibits hypoxia-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells.

Authors:  Guang-Jin Yuan; Qian-Wen Li; Shun-Lin Shan; Wu-Ming Wang; Sen Jiang; Xi-Ming Xu
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

2.  Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions.

Authors:  Meinhard Schiller; Sylviane Dennler; Ulf Anderegg; Agatha Kokot; Jan C Simon; Thomas A Luger; Alain Mauviel; Markus Böhm
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

3.  The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines.

Authors:  Reiko Kimura-Tsuchiya; Takeshi Ishikawa; Satoshi Kokura; Katsura Mizushima; Satoko Adachi; Manabu Okajima; Tatsuzo Matsuyama; Tetsuya Okayama; Naoyuki Sakamoto; Kazuhiro Katada; Kazuhiro Kamada; Kazuhiko Uchiyama; Osamu Handa; Tomohisa Takagi; Nobuaki Yagi; Yuji Naito; Yoshito Itoh
Journal:  J Clin Biochem Nutr       Date:  2014-05-13       Impact factor: 3.114

4.  Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro.

Authors:  Y Sawaji; T Sato; A Takeuchi; M Hirata; A Ito
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

5.  Hyperthermia-induced NDRG2 upregulation inhibits the invasion of human hepatocellular carcinoma via suppressing ERK1/2 signaling pathway.

Authors:  Yan Guo; Ji Ma; Lin Wu; Qianrong Wang; Xia Li; Xiaoming Li; Yuan Zhang; Jian Zhang; Libo Yao; Jing Zhang; Wenchao Liu
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.